News
DA Davidson lowered the firm’s price target on Nice (NICE) to $180 from $200 and keeps a Buy rating on the shares as part of a broader research note updating estimates within the firm’s ...
Olipudase alfa for treating acid sphingomyelinase deficiency (Niemann–Pick disease) type AB and type B HST32 2 April 2025 2 April 2025 Efanesoctocog alfa for treating and preventing bleeding episodes ...
Olipudase alfa for treating acid sphingomyelinase deficiency (Niemann–Pick disease) type AB and type B HST32 2 April 2025 2 April 2025 Efanesoctocog alfa for treating and preventing bleeding episodes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback